Search
Menu
Gentec Electro-Optics Inc   - Measure With Gentec Accuracy LB

FDA Approves Coherent Laser for AMD Treatment

Facebook X LinkedIn Email
SANTA CLARA, Calif., April 17 -- The US Food and Drug Administration (FDA) has approved Coherent Inc.'s Opal photoactivator and Visudyne (verteporfin for injection) therapy to treat the wet form of age-related macular degeneration, or AMD. The disease is the leading cause of blindness in the western world in people over the age of 50. According to Coherent, the FDA concluded that Visudyne therapy was most appropriate for patients with predominantly classic subfoveal choroidal neovascularization (CNV). Patients suffering from this form of AMD can lose their ability to read, drive and recognize...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: April 2000
    diode lasersNews & FeaturesLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.